Clinical trials
catalyst calendar across sponsors →Studies where VCYT is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
1 observational
Held by 13 tracked-famous managers (Artisan Partners Limited Partnership, Point72 Asset Management, L.P., D. E. Shaw & Co., Inc., AQR CAPITAL MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, +8 more) · FINRA short interest 4.8 days to cover (settled 2026-07-31) · insider 90d: 0 buys / 9 sells · government filings 180d: 1 congress / 0 executive
| Study | Phase | Status | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|
| Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab ClassifierNCT06426628observationalNumber of invasive diagnostic procedures | — | Recruiting | Pulmonary Nodule, Solitary, Lung Cancer | 2,400 | 2024-12-31 | 2024-11-13 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19